Dr Lal PathLabs to acquire 70% stake in genomics firm SN Genelab for up to ₹168 crore

Diagnostic services provider Dr Lal PathLabs Ltd on Thursday (September 24) said it has approved the acquisition of a 70% stake in SN Genelab Private Ltd (SN Gene) for a cash consideration of up to ₹168 crore, along with a performance-linked earn-out capped at ₹31.5 crore.The Board of Directors app…